Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to explore options for preventing and reducing symptoms of radiation esophagitis (RE). The researchers will also look what symptoms participants experience, and whether there are differences in weight loss in participants.


Clinical Trial Description

Embedded Randomized Study to Assess Two-Stage Consent Design: There will be two separate randomizations in this study, one vs. two-stage consent and sucralfate vs. control. The will first approach patients and explain that we are comparing different methods of informing patients about trials. If the patients do not wish to participate in the consent trial, participants will be approached for consent onto the therapeutic trial using the traditional onestage research consent. Patients who decline or who are not approached to take part in the randomized compression of consent methods based on physician discretion, may still take part in the randomized comparison of sucralfate vs. control (therapeutic trial). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05659576
Study type Interventional
Source Memorial Sloan Kettering Cancer Center
Contact Jacob Shin, MD
Phone 848-225-6436
Email shinj2@mskcc.org
Status Recruiting
Phase Phase 2
Start date December 13, 2022
Completion date December 2025